Patents by Inventor Sandor Bernath

Sandor Bernath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication
    Publication number: 20150366852
    Abstract: O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.
    Type: Application
    Filed: June 23, 2015
    Publication date: December 24, 2015
    Inventors: Peter Literati Nagy, Jesse Roth, Zoltan Szilvassy, Kalman Tory, Michael Brownstein, Kálmán Takács, Laszlo Vigh, József Mandl, Balázs Sümegi, Sandor Bernath, Attila Kolonics, Gábor Balogh, Janos Egri
  • Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity
    Publication number: 20090281143
    Abstract: O-(3-Piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime or a pharmaceutically acceptable acid addition salt thereof is administered to patients suffering from overweight or obesity and treated with a cannabinoid CB1 receptor antagonist such as rimonabant to reduce overweight or obesity and, preferably, reduce one or more unfavourable psychiatric side effects of the cannabinoid CB1 receptor antagonist.
    Type: Application
    Filed: December 10, 2008
    Publication date: November 12, 2009
    Inventors: Peter Literati Nagy, Zoltan Szilvassy, Kalman Tory, Attila Kolonics, Sandor Bernath, Laszlo Vigh, Jesse Roth, G. Alexander Fleming, Michael Brownstein, Janos Egri
  • Pharmaceutical Composition Containing an Extract of a Solidago Species
    Publication number: 20090214677
    Abstract: An extract of a part of a Solidago species, wherein said part has grown above the earth, or the solid residue remaining after the removal of the solvent content of the extract as the active ingredient is used for the regeneration of the organism of a mammal after long-lasting immobilization, anorexia, states following a disease or accompanied by weight loss as well as for muscle development or muscle growth during muscle developing training, treatment of muscular strain and adaptation to high-altitude as well as for the prevention or treatment of neurodegenerative diseases and/or motility disorders of the gastrointestinal system.
    Type: Application
    Filed: August 30, 2006
    Publication date: August 27, 2009
    Applicant: ELSO MAGYAR BIODROG KUTATÓ ÉS FEJLESZTO KFT
    Inventors: Péter Literati Nagy, Kalman Tory, Attila Kolonics, Agnes Keri, Lajos Laszlo, Laszlo Jaszlits, Agnes Bajza, Sandor Bernath, Laszlo Vigh, Tibor Bodnar, Janos Egri
  • Composition for the Treatment of Diabetic Periodontitis
    Publication number: 20090130234
    Abstract: The invention refers to the use of an extract of a part of a Solidago species, wherein said part has grown above the earth, or the solid residue remaining after the removal of the solvent content of the extract as the active agent for the preparation of a pharmaceutical composition suitable for the treatment of diabetic periodontitis.
    Type: Application
    Filed: October 10, 2006
    Publication date: May 21, 2009
    Inventors: Peter Literati Nagy, Zsolt Lohinai, Kalman Tory, Attila Kolonics, Agnes Keri, Orsolya Rigo, Andras Huszak, Balazs Zahonyi, Sandor Bernath, Laszlo Vigh, Tibor Bodnar, Jonos Egri
  • Prevention and Treatment of Obesity
    Publication number: 20080108673
    Abstract: O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or the reduction of the rate of body weight.
    Type: Application
    Filed: March 19, 2007
    Publication date: May 8, 2008
    Inventors: Peter Literati Nagy, Zoltan Szilvassy, Kalman Tory, Laszlo Vigh, Kalman Takacs, Jozsef Mandl, Balazs Sumegi, Sandor Bernath, Attila Kolonics, Gabor Balogh, Janos Egri
  • Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication
    Publication number: 20080108602
    Abstract: O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.
    Type: Application
    Filed: March 19, 2007
    Publication date: May 8, 2008
    Inventors: Peter Literati Nagy, Jesse Roth, Zoltan Szilvassy, Kalman Tory, Mike Brownstein, Kalman Takacs, Laszlo Vigh, Jozsef Mandi, Balazs Sumegi, Sandor Bernath, Attila Kolonics, Gabor Balogh, Janos Egri